Elevance Health, Inc. (ELV) To Go Ex-Dividend on December 4th

Elevance Health, Inc. (NYSE:ELV) declared a quarterly dividend on Tuesday, October 20th. Shareholders of record on Friday, December 4th will be paid a dividend of $1.72 per share on Friday, December 18th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, December 4th.

Elevance Health has increased its dividend payment by an average of 0.1% per year over the last three years and has increased its dividend every year for the last 14 years. Elevance Health has a payout ratio of 17.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Elevance Health to earn $29.41 per share next year, which means the company should continue to be able to cover its $6.88 annual dividend with an expected future payout ratio of 23.4%.

Elevance Health Stock Down 1.1%

NYSE:ELV opened at $435.26 on Thursday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.52 and a current ratio of 1.52. Elevance Health has a 52-week low of $274.84 and a 52-week high of $450.69. The company has a market cap of $94.39 billion, a price-to-earnings ratio of 19.34, a P/E/G ratio of 2.29 and a beta of 0.70. The stock’s fifty day moving average price is $406.59 and its two-hundred day moving average price is $389.52.

Elevance Health (NYSE:ELV) last posted its quarterly earnings results on Wednesday, October 21st. The company reported $6.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.71 by $2.28. The business had revenue of $50.44 billion for the quarter, compared to analysts’ expectations of $49.28 billion. Elevance Health had a return on equity of 14.64% and a net margin of 2.47%. The firm’s quarterly revenue was up .7% compared to the same quarter last year. During the same quarter last year, the business earned $6.03 earnings per share. On average, analysts anticipate that Elevance Health will post 27.20 EPS for the current year.

Key Stories Impacting Elevance Health

Here are the key news stories impacting Elevance Health this week:

• Positive Sentiment: Elevance raised its 2026 adjusted EPS outlook, with company commentary indicating a new baseline of at least $26.75 and other coverage citing guidance of at least $29. The company also expects at least 12% adjusted EPS growth in 2027 from the higher earnings base. Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
• Positive Sentiment: Improved medical-cost management and disciplined spending helped drive the earnings beat. Carelon was a key growth contributor, while its cancer program reduced avoidable inpatient admissions by 15%, supporting the company’s diversification and longer-term margin potential. Elevance lifts 2026 profit forecast on better medical cost management
• Positive Sentiment: The quarterly dividend remains $1.72 per share, or $6.88 annualized, providing a roughly 1.6% yield and signaling continued shareholder returns. Elevance Health dividend information
• Neutral Sentiment: Jeff Park will become president of Carelon on December 1, bringing new leadership to a strategically important business expected to support future growth. Elevance Health Names Jeff Park President of Carelon
• Negative Sentiment: Investors remain concerned about the durability of the recovery. Nine-month operating gain declined 25.7%, and Health Benefits margins—particularly in Medicaid—remain pressured. Medical membership also fell, meaning the improved quarter may not fully resolve underlying profitability concerns. Elevance Health: Better Results, But Not Enough To Buy

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a diversified health benefits company that provides health insurance and related services in the United States. Its offerings serve employers, individuals and families, as well as members of government-sponsored programs, including Medicare and Medicaid. The company provides medical, pharmacy, behavioral health and other benefits through a range of health plans and specialty products.

Elevance Health operates its health benefits businesses through a portfolio that includes Blue Cross and Blue Shield-affiliated plans and other insurance offerings.